Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Clene Inc. (NASDAQ: CLNN) Announces Plan to Submit Briefing Book to FDA Preceding Type C Interaction

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to enhancing mitochondrial health and protecting neuronal function to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), have revealed plans to submit a briefing book to the U.S. Food and Drug Administration (“FDA”) by […]

D-Wave Quantum Inc. (NYSE: QBTS) Reveals Findings of Hyperion Research Quantum Optimization ROI Study and Announces Nomination for Technology Impact Awards

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, recently announced the findings of a recent study it commissioned with Hyperion Research on enterprise quantum computing adoption plans. Notably, a majority of the surveyed businesses actively engaged in quantum computing anticipate significant […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Issuance of Three New Patents, Growing Portfolio to 46 Granted Patents Worldwide

Lexaria’s multi-patented DehydraTECH(TM) “drug delivery platform technology” offers proven increased bioavailability, enhancing the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery, helping with speed of onset, and brain absorption of APIs. Strong patents covering this important technology are a critical factor for Lexaria. A robust patent portfolio has always […]

Annovis Bio Inc. (NYSE: ANVS) Files New Composition of Matter Patent for Buntanetap

Annovis Bio (NYSE: ANVS), a pioneering biotechnology company, committed to addressing unmet medical needs through innovative research and development efforts, particularly in Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions, is continuing to make significant strides in the field of neurodegenerative diseases with its latest patent filings. The recent announcement is the filing of a […]

GEMXX Corp. (GEMZ) Plans to Fully Harness Potential of Two Promising Target Basins in Latin America, Bolstered by Recent Strategic Addition to Primary Investment Target’s Board

GEMXX (OTC: GEMZ), a mine-to-market gold, gemstone, and jewelry producer with global reach, earlier this month signed a definitive agreement with Latin America Partners (“LEP”), an emerging leader and an independent E&P company involved in exploring significant hydrocarbon reserves in Latin America. The agreement kickstarted a collaboration to drill four test wells in a highly […]

 

From Our Blog

BlueSky AI Inc. (BSAI) Expands Market Presence with Strategic Milestones in AI Infrastructure

July 3, 2025

BlueSky AI (OTC: BSAI) has rapidly emerged as a key player in modular AI data center infrastructure, achieving major milestones in the past two years. The company has moved from concept to execution with its scalable SkyMod solutions, stepped up its market visibility by upgrading to the OTCID tier, and partnered with industry accelerators, marking significant […]

Rotate your device 90° to view site.